Ion channels, receptors, agonists and antagonists

被引:0
|
作者
Weir, Cameron J. [1 ]
机构
[1] Ninewells Hosp & Med Sch, Anaesthetist, Dundee, Scotland
来源
关键词
G-protein-coupled receptors; inverse agonists; ligand-gated ion channels; voltage-gated ion channels;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This article describes the physiology of ion channels and the principal molecular mechanisms responsible for modulating their activity by commonly used drugs in anaesthesia and intensive care. The concept of efficient and selective transport of ions across 'impermeable' plasma membranes is introduced, together with the mechanisms influencing electro-chemical signalling within cells. The classification and composition of voltage-gated ion channels are described in the context of their contribution to action potential generation in excitable cells. Druge receptor interaction of the four main classes of receptor, that is, ligand-gated ion channels (in particular Cys-loop channels), G-protein-coupled, enzyme-linked and nuclear receptors, are described together with an overview of the various signal-transduction mechanisms adopted by metabotropic receptors to control cellular function. Finally, the principles of drugereceptor interaction of agonists, antagonists and inverse agonists are discussed in relation to their affinity, efficacy and potency.
引用
收藏
页码:410 / 416
页数:7
相关论文
共 50 条
  • [41] INTERACTIONS OF VASOPRESSIN AGONISTS AND ANTAGONISTS WITH MEMBRANE-RECEPTORS
    FAHRENHOLZ, F
    BOER, R
    CRAUSE, P
    FRITZSCH, G
    GRZONKA, Z
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 100 (01) : 47 - 58
  • [42] Current knowledge on the antagonists and inverse agonists of cannabinoid receptors
    Muccioli, GG
    Lambert, DM
    CURRENT MEDICINAL CHEMISTRY, 2005, 12 (12) : 1361 - 1394
  • [43] EFFECTS OF IONS ON THE BINDING OF AGONISTS AND ANTAGONISTS TO MUSCARINIC RECEPTORS
    BIRDSALL, NJM
    BURGEN, ASV
    HULME, EC
    WELLS, JW
    BRITISH JOURNAL OF PHARMACOLOGY, 1979, 67 (03) : 371 - 377
  • [44] Small molecule agonists and antagonists for the LH and FSH receptors
    Guo, T
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (11) : 1555 - 1564
  • [45] The melanocortin receptors: Agonists, antagonists, and the hormonal control of pigmentation
    Cone, RD
    Lu, DS
    Koppula, S
    Vage, DI
    Klungland, H
    Boston, B
    Chen, WB
    Orth, DN
    Pouton, C
    Kesterson, RA
    RECENT PROGRESS IN HORMONE RESEARCH, VOL 51: PROCEEDINGS OF THE 1995 CONFERENCE, 1996, 51 : 287 - 318
  • [46] Metabotropic glutamate receptors: Agonists, antagonists and allosteric modulators
    Augelli-Szafran, CE
    Schwarz, RD
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 38, 2003, 38 : 21 - 30
  • [47] THE DEVELOPMENT OF POTENT PEPTIDE AGONISTS AND ANTAGONISTS FOR THE ENDOTHELIN RECEPTORS
    CODY, WL
    DOHERTY, AM
    BIOPOLYMERS, 1995, 37 (02) : 89 - 104
  • [48] QSPR analysis of some agonists and antagonists of α-adrenergic receptors
    Kawczak, Piotr
    Bober, Leszek
    Baczek, Tomasz
    MEDICINAL CHEMISTRY RESEARCH, 2015, 24 (01) : 372 - 382
  • [49] Ion channels and receptors as targets
    Iversen, LL
    PROGRESS IN NEUROPHARMACOLOGY AND NEUROTOXICOLOGY OF PESTICIDES AND DRUGS, 1999, (232): : 1 - 4